Updated COVID-19 Vaccines Available at CVS Pharmacy and MinuteClinic Across the U.S.
Appointments can be scheduled through the CVS Health app or CVS.com and walk-ins are acceptedOriginally published on CVS Health Company...
COVID-19
Clinical Trial for an Oral Drug to Treat Ebola is Registered in the Pan African Clinical Trials Database and is Ready to Go, As the Largest Ebola Outbreak Continues to Expand in DR Congo
SHELTON, CT / ACCESS Newswire / September 8, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
Back-to-School Health Checklist: What Parents Can Do To Help Kids Start the School Year Strong
Originally published on CVS Health Company Newsroom WOONSOCKET, RI / ACCESS Newswire / September 3, 2026 / As summer winds...
Manufacturing PMI® at 54.6%; August 2026 ISM® Manufacturing PMI® Report
New Orders Growing; Production Growing; Employment Growing; Supplier Deliveries Slowing; Raw Materials Inventories Growing; Customers' Inventories Too Low; Prices Increasing;...
While Measles Cases Continue to Increase in The USA and Globally, NanoViricides is Getting Ready for Clinical Trials of Its Revolutionary Broad-spectrum Drug Candidate NV-387 as A Treatment for Measles
SHELTON, CT / ACCESS Newswire / August 31, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"),...
CVS Pharmacy(R) and MinuteClinic(R) Now Offering Updated Flu Vaccines Nationwide
CVS Health survey finds more than 60 percent of consumers say they are likely to get a flu shot this...
Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines
CAMBRIDGE, MA / ACCESS Newswire / August 27, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and...
How Avel eCare’s Virtual Health System Helps Rural Physicians Stay in Their Communities
See how Avel's Virtual Health System supports rural physicians through collaboration, reduced burnout, and better access to specialist care. SIOUX...
The Emmes Group Appoints Dr. Rama Kondru as Chief Executive Officer
ROCKVILLE, Md., Aug. 24, 2026 /PRNewswire/ -- The Emmes Group today announced that its Board of Directors has appointed Dr....
The Emmes Group Appoints Dr. Rama Kondru as Chief Executive Officer
ROCKVILLE, Md., Aug. 24, 2026 /PRNewswire/ -- The Emmes Group today announced that its Board of Directors has appointed Dr....
UPDATE Integrity Urgent Care Clinic Opens in Murphy, Texas
Murphy’s newest urgent care clinic offers accessible, high-quality health care you can count onKey facts of this press release: Integrity...
Hemostemix Commercializes Its Vascular Dementia Clinical Trial of VesCell(TM) Under LARTA
Leading cognitive-disorders specialist, Dr. William Shankle, will discuss vascular cognitive impairment, vascular dementia and the proposed clinical trial of VesCell™...
Revive Therapeutics Outlines Strategy to Build a Biodefence and Pandemic Preparedness Therapeutics Portfolio
Positive DRDC findings support the next phase for bucillamine as Revive plans to pursue government-backed development opportunities, expand intellectual property...
The Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo to Fight the Current Largest Ever and Expanding Ebola Outbreak to Begin Soon
SHELTON, CT / ACCESS Newswire / August 18, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
SHELTON, CT / ACCESS Newswire / August 10, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA
mFLUSIVA becomes Moderna's fifth approved product globally and fourth FDA-approved productCompany expects supply to be available in select retailers in...
Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna’s Investigational Vaccine Against Bundibugyo Ebolavirus
Phase 1 trial will evaluate safety and immune response for a strain of Ebola virus disease with no licensed vaccines...
Manufacturing PMI® at 55.6%; July 2026 ISM® Manufacturing PMI® Report
New Orders Growing; Production Growing; Employment Growing; Supplier Deliveries Slowing; Raw Materials Inventories Growing; Customers' Inventories Too Low; Prices Increasing;...
DataMeds AI’s Corexa Pharmacy Launches Tollo Health’s Tollovid(R) and Galactovid(TM)
Launch targets acute viral infection and Long COVID markets through www.CorexaRx.com/Store TAMPA, FL / ACCESS Newswire / July 31, 2026...
Hemostemix Closes Second Tranche of Private Placement and Obtains Extension to August 14, 2026
Calgary, Alberta--(Newsfile Corp. - July 30, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased...